TNFRSF17 and plasma cell myeloma: In contrast, the percentage of BCMA-positive myeloma cells ranged from 1.44 to 96.44%, with only 10 patients (35.71%) expressing BCMA on more than 50% of myeloma cells (Fig. 1b).